NCT04369222

Brief Summary

Fundamental aspects of reproductive function are established in fetal life and there is a present increased awareness of the potential effects of fetal exposures on reproductive health of offspring. Experimental studies strongly suggest detrimental effects of prenatal exposure to mild analgesics such as acetaminophen (e.g. paracetamol) and non-steroidal anti-inflammatory drugs, NSAIDs (e.g. ibuprofen and acetylsalicylic acid) on male as well as female gonadal development. Declining fertility has become a growing problem in developing countries, potentially resulting in severe socioeconomic challenges, and fetal exposure of mild analgesics causes part of these alarming observations.This is the first prospective human study designed primarily to assess the effect of fetal exposure of mild analgesics on male and female reproductive function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
685

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 30, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

2.8 years

First QC Date

April 20, 2020

Last Update Submit

July 7, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Ovarian volume (female infants)

    Ovarian volumen, measured by abdominal ultrasound

    2.5 months old

  • Ovarian follicle count (female infants)

    Ovarian follicle count, measured by abdominal ultrasound

    2.5 months old

  • Blood sample (female infants)

    Serum metabolites Anti MĂ¼llarian Hormone (AMH)

    2.5 months old

  • Testes volumen (male infants)

    Testes volumen, measured by ultrasound

    2.5 months old

  • Blood sample (male infants)

    Serum metabolites testosterone, free testosterone.

    2.5 months old

Secondary Outcomes (43)

  • Length (male and female infants)

    2.5 months old

  • Weight (male and female infants)

    2.5 months old

  • Head circumference (male and female infants)

    2.5 months old

  • Abdominal circumference (male and female infants)

    2.5 months old

  • Height (fathers)

    Gestational week 12

  • +38 more secondary outcomes

Study Arms (2)

Controls

Children born from mothers with no consumption of mild analgesics 3 months before or during pregnancy

Exposed

Children born from mothers with consumption of mild analgesics 3 months before or during pregnancy

Other: Observational

Interventions

Maternal consumption of mild analgesics

Also known as: Acetaminophen, Non steroidal antiinflammatory drugs, Acetyl salicylic acid
Exposed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study is a population based prospective cohort study of 600 families (healthy pregnant mothers, biological fathers and their healthy male/female offspring. Pregnant women, meeting the inclusion criteria, and the fathers-to-be followed at the Department of Obstetrics, Rigshospitalet will be invited to participate. There are two groups of participants in this study: 1. Healthy infants recruited specifically for this study 2. The parents, i.e. the mother and father, of the healthy infants The two groups will include the following numbers (approximately) of participants: 1. 600 healthy infants (based on expected son to daughter ratio of 105 to 100 in Denmark, we expect approximately equal distribution of boys and girl). 2. 600 mothers and 600 fathers of healthy infants

You may qualify if:

  • Infants:
  • Singleton pregnancies
  • Term pregnancy (week 37+0 to 42+0)
  • Parents:
  • Maternal and paternal Caucasian origin
  • Maternal pre-pregnancy BMI between 18 and 35 kg/m2

You may not qualify if:

  • Infants:
  • Fetal malformations or chromosomal disorders
  • Parents:
  • Serious maternal illness, including pre-existing maternal diabetes or thyroid gland diseases
  • Gestational diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Growth and Reproduction, Rigshospitalet

Copenhagen, 2100, Denmark

Location

Department of Obstetrics and Section of fetal medicine, Rigshospitalet

Copenhagen, 2100, Denmark

Location

Related Publications (24)

  • Dean A, van den Driesche S, Wang Y, McKinnell C, Macpherson S, Eddie SL, Kinnell H, Hurtado-Gonzalez P, Chambers TJ, Stevenson K, Wolfinger E, Hrabalkova L, Calarrao A, Bayne RA, Hagen CP, Mitchell RT, Anderson RA, Sharpe RM. Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences. Sci Rep. 2016 Jan 27;6:19789. doi: 10.1038/srep19789.

    PMID: 26813099BACKGROUND
  • Arendrup FS, Mazaud-Guittot S, Jegou B, Kristensen DM. EDC IMPACT: Is exposure during pregnancy to acetaminophen/paracetamol disrupting female reproductive development? Endocr Connect. 2018 Jan;7(1):149-158. doi: 10.1530/EC-17-0298. Epub 2018 Jan 5.

    PMID: 29305399BACKGROUND
  • Kristensen DM, Mazaud-Guittot S, Gaudriault P, Lesne L, Serrano T, Main KM, Jegou B. Analgesic use - prevalence, biomonitoring and endocrine and reproductive effects. Nat Rev Endocrinol. 2016 Jul;12(7):381-93. doi: 10.1038/nrendo.2016.55. Epub 2016 May 6.

    PMID: 27150289BACKGROUND
  • Kristensen DM, Hass U, Lesne L, Lottrup G, Jacobsen PR, Desdoits-Lethimonier C, Boberg J, Petersen JH, Toppari J, Jensen TK, Brunak S, Skakkebaek NE, Nellemann C, Main KM, Jegou B, Leffers H. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod. 2011 Jan;26(1):235-44. doi: 10.1093/humrep/deq323. Epub 2010 Nov 8.

    PMID: 21059752BACKGROUND
  • Holm JB, Mazaud-Guittot S, Danneskiold-Samsoe NB, Chalmey C, Jensen B, Norregard MM, Hansen CH, Styrishave B, Svingen T, Vinggaard AM, Koch HM, Bowles J, Koopman P, Jegou B, Kristiansen K, Kristensen DM. Intrauterine Exposure to Paracetamol and Aniline Impairs Female Reproductive Development by Reducing Follicle Reserves and Fertility. Toxicol Sci. 2016 Mar;150(1):178-89. doi: 10.1093/toxsci/kfv332. Epub 2016 Jan 5.

    PMID: 26732887BACKGROUND
  • BAKER TG. A QUANTITATIVE AND CYTOLOGICAL STUDY OF GERM CELLS IN HUMAN OVARIES. Proc R Soc Lond B Biol Sci. 1963 Oct 22;158:417-33. doi: 10.1098/rspb.1963.0055. No abstract available.

    PMID: 14070052BACKGROUND
  • Reel JR, Lawton AD, Lamb JC 4th. Reproductive toxicity evaluation of acetaminophen in Swiss CD-1 mice using a continuous breeding protocol. Fundam Appl Toxicol. 1992 Feb;18(2):233-9. doi: 10.1016/0272-0590(92)90051-i.

    PMID: 1601223BACKGROUND
  • Johansson HK, Jacobsen PR, Hass U, Svingen T, Vinggaard AM, Isling LK, Axelstad M, Christiansen S, Boberg J. Perinatal exposure to mixtures of endocrine disrupting chemicals reduces female rat follicle reserves and accelerates reproductive aging. Reprod Toxicol. 2016 Jun;61:186-94. doi: 10.1016/j.reprotox.2016.03.045. Epub 2016 Apr 2.

    PMID: 27049580BACKGROUND
  • Ersboll AS, Hedegaard M, Damm P, Johansen M, Tabor A, Hegaard HK. Changes in the pattern of paracetamol use in the periconception period in a Danish cohort. Acta Obstet Gynecol Scand. 2015 Aug;94(8):898-903. doi: 10.1111/aogs.12667. Epub 2015 May 29.

    PMID: 25939806BACKGROUND
  • Lind DV, Main KM, Kyhl HB, Kristensen DM, Toppari J, Andersen HR, Andersen MS, Skakkebaek NE, Jensen TK. Maternal use of mild analgesics during pregnancy associated with reduced anogenital distance in sons: a cohort study of 1027 mother-child pairs. Hum Reprod. 2017 Jan;32(1):223-231. doi: 10.1093/humrep/dew285. Epub 2016 Nov 16.

    PMID: 27852690BACKGROUND
  • Rebordosa C, Zelop CM, Kogevinas M, Sorensen HT, Olsen J. Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study. J Matern Fetal Neonatal Med. 2010 May;23(5):371-8. doi: 10.3109/14767050903334877.

    PMID: 19929241BACKGROUND
  • Nitsche JF, Patil AS, Langman LJ, Penn HJ, Derleth D, Watson WJ, Brost BC. Transplacental Passage of Acetaminophen in Term Pregnancy. Am J Perinatol. 2017 May;34(6):541-543. doi: 10.1055/s-0036-1593845. Epub 2016 Nov 2.

    PMID: 27806383BACKGROUND
  • Myrskyla M, Kohler HP, Billari FC. Advances in development reverse fertility declines. Nature. 2009 Aug 6;460(7256):741-3. doi: 10.1038/nature08230.

    PMID: 19661915BACKGROUND
  • Tromp M, Ravelli AC, Reitsma JB, Bonsel GJ, Mol BW. Increasing maternal age at first pregnancy planning: health outcomes and associated costs. J Epidemiol Community Health. 2011 Dec;65(12):1083-90. doi: 10.1136/jech.2009.095422. Epub 2010 Aug 13.

    PMID: 20709858BACKGROUND
  • Gallavan RH Jr, Holson JF, Stump DG, Knapp JF, Reynolds VL. Interpreting the toxicologic significance of alterations in anogenital distance: potential for confounding effects of progeny body weights. Reprod Toxicol. 1999 Sep-Oct;13(5):383-90. doi: 10.1016/s0890-6238(99)00036-2.

    PMID: 10560587BACKGROUND
  • Juul A, Almstrup K, Andersson AM, Jensen TK, Jorgensen N, Main KM, Rajpert-De Meyts E, Toppari J, Skakkebaek NE. Possible fetal determinants of male infertility. Nat Rev Endocrinol. 2014 Sep;10(9):553-62. doi: 10.1038/nrendo.2014.97. Epub 2014 Jun 17.

    PMID: 24935122BACKGROUND
  • Dean A, Sharpe RM. Clinical review: Anogenital distance or digit length ratio as measures of fetal androgen exposure: relationship to male reproductive development and its disorders. J Clin Endocrinol Metab. 2013 Jun;98(6):2230-8. doi: 10.1210/jc.2012-4057. Epub 2013 Apr 8.

    PMID: 23569219BACKGROUND
  • Leverrier-Penna S, Mitchell RT, Becker E, Lecante L, Ben Maamar M, Homer N, Lavoue V, Kristensen DM, Dejucq-Rainsford N, Jegou B, Mazaud-Guittot S. Ibuprofen is deleterious for the development of first trimester human fetal ovary ex vivo. Hum Reprod. 2018 Mar 1;33(3):482-493. doi: 10.1093/humrep/dex383.

    PMID: 29408962BACKGROUND
  • Snijder CA, Kortenkamp A, Steegers EA, Jaddoe VW, Hofman A, Hass U, Burdorf A. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod. 2012 Apr;27(4):1191-201. doi: 10.1093/humrep/der474. Epub 2012 Feb 2.

    PMID: 22301570BACKGROUND
  • Gilboa Y, Perlman S, Kivilevitch Z, Messing B, Achiron R. Prenatal Anogenital Distance Is Shorter in Fetuses With Hypospadias. J Ultrasound Med. 2017 Jan;36(1):175-182. doi: 10.7863/ultra.16.01006. Epub 2016 Nov 28.

    PMID: 27925677BACKGROUND
  • Mendiola J, Stahlhut RW, Jorgensen N, Liu F, Swan SH. Shorter anogenital distance predicts poorer semen quality in young men in Rochester, New York. Environ Health Perspect. 2011 Jul;119(7):958-63. doi: 10.1289/ehp.1103421. Epub 2011 Mar 4.

    PMID: 21377950BACKGROUND
  • Kuiri-Hanninen T, Sankilampi U, Dunkel L. Activation of the hypothalamic-pituitary-gonadal axis in infancy: minipuberty. Horm Res Paediatr. 2014;82(2):73-80. doi: 10.1159/000362414. Epub 2014 Jul 5.

    PMID: 25012863BACKGROUND
  • Lanciotti L, Cofini M, Leonardi A, Penta L, Esposito S. Up-To-Date Review About Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life. Front Endocrinol (Lausanne). 2018 Jul 23;9:410. doi: 10.3389/fendo.2018.00410. eCollection 2018.

    PMID: 30093882BACKGROUND
  • Fischer MB, Mola G, Rom AL, Frederiksen H, Johannsen TH, Sundberg K, Hegaard HK, Juul A, Hagen CP. Ovarian and Uterine Morphology in Minipuberty: Associations With Reproductive Hormones: a COPANA Study of 302 Girls. J Clin Endocrinol Metab. 2025 Mar 17;110(4):1015-1022. doi: 10.1210/clinem/dgae678.

Biospecimen

Retention: SAMPLES WITH DNA

DNA EDTA-Blood Serum

MeSH Terms

Interventions

Watchful WaitingAcetaminophen

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services AdministrationAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Anders Juul, Professor

    Department of Growth and Reproduction, Rigshospitalet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 20, 2020

First Posted

April 30, 2020

Study Start

March 1, 2020

Primary Completion

November 30, 2022

Study Completion

November 30, 2022

Last Updated

July 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations